Abstract
The insulin-like growth factors (IGF-1 and -2) are ubiquitous polypeptides that mediate the activity of growth hormone. In many tissues they serve as paracrine or autocrine factors (1). Second only to the liver, the skeleton is an exceptionally rich source of IGF-1 where it is both synthesized and stored. During bone remodeling, both systemic and skeletal IGF-1 play a major role in the recruitment and differentiation of osteoblasts (2, 3). In the course of bone resorption, the initiating bone remodeling event, matrix-bound IGFs are released and become critical coupling agents linking the processes of bone resorption and bone formation (2). Efforts to establish a relationship between synthesis of rapid bone loss or impaired bone formation and changes in the skeletal or circulatory IGF system have led to several hypotheses suggesting that IGF-1 is of pathophysiologic significance (2). Two recent studies, one showing an age-associated decline in skeletal IGF-1, and the other relating serum IGF-1 to bone density, have strengthened the view that the skeletal IGF regulatory system is important in states of impaired bone remodeling (4, 5). Two additional studies have demonstrated a strong relationship between serum IGF-1 and bone mineral density in men with idiopathic osteoporosis (6, 7). Based on these lines of evidence and the concept that bone density at any age is strongly dependent on peak bone mass, our group has considered IGF-1 to be a key factor in the acquisition of peak bone mass. In this paper, data will be presented which suggest that in several inbred strains of mice and in humans, osteoporotic male idiopathic IGF-1 is an important determinant of bone mineral density (BMD).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Jones JL, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3–32.
Rosen CJ, Donahue LR, Hunter SJ. IGFs and bone: the osteoporosis connection. Proc Soc Exp Biol Med 1994; 206: 83–102.
Hayden JM, Mohan S, Baylink DJ. The insulin-like growth factor system and the coupling of formation to resorption. Bone 1995; 17: 93–8S.
Nicholas V, Prewett A, Bettica P, Mohan S, Finkleman RD, Baylink DJ, et al. Age-related decreases in IGF-1 and transforming growth factor-/3 in femoral cortical bone from both men and women: implications for bone loss in aging. J Clin Endocrinol Metab 1994; 78: 1011–6.
Mohan S, Baylink DJ. Development of a simple valid method for the complete removal of IGF binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 1995; 80: 637–47.
Ljunghall S, Johansson AG, Buman P, Kampe O, Lindh E, Karlsson FA. Low plasma levels of IGF-1 in male patients with idiopathic osteoporosis. J Intern Med 1992; 232: 59–64.
Reed BY, Zerwekh JE, Sakhaeek K, Breslau NA, Gottschalk F, Pak CYC. Serum IGF-1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 1995; 10: 1218–24.
Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. Genetic variability in adult bone density among inbred strains of mice. Bone 1996; 18: 397–403.
Jorgensen JOL, Thuesen L, Ingemann-Hansen T, Pedersen SA, Jorgensen JU, Skakkebaek NES, et al. Beneficial effects of GH treatment in GH deficient adults. Lancet 1989; 1: 1221–5.
Donahue LR, Beamer WG, Rosen CJ. Parathyroid hormone improves bone density in mice with growth hormone deficiency and IGF-1 deficiency. J Bone Miner Res 1995; 10: 523.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Rosen, C.J., Donahue, L.R., Beamer, W.G., Adler, R.A., Kurland, E.S., Bilezikian, J.P. (1998). IGF-1 and Osteoporosis: Lessons from Mice and Men. In: Burckhardt, P., Dawson-Hughes, B., Heaney, R.P. (eds) Nutritional Aspects of Osteoporosis. Proceedings in the Serono Symposia USA Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2228-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2228-6_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7463-6
Online ISBN: 978-1-4612-2228-6
eBook Packages: Springer Book Archive